RAYMOND V LANDES

Allopathic & Osteopathic Physicians|Colon & Rectal Surgery ROCHESTER HILLS, MI NPI 1851367593

General Payments — all program years on this page

$2,020.85

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $597.72 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $597.7220

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $234.277
Janssen Biotech, Inc. $131.006
Janssen Scientific Affairs, LLC $111.751
Lilly USA, LLC $64.373
Takeda Pharmaceuticals U.S.A., Inc. $56.333

By program year

Program yearAmountRecords
2018 $67.606
2019 $244.7515
2020 $78.685
2021 $346.5416
2022 $311.4318
2023 $374.1320
2024 $597.7220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078774691 Janssen Biotech, Inc. $21.88 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078774745 Janssen Biotech, Inc. $18.39 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078774987 Janssen Biotech, Inc. $30.88 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078775029 Janssen Biotech, Inc. $21.42 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078775037 Janssen Biotech, Inc. $18.30 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078775269 Janssen Biotech, Inc. $20.13 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078852918 Janssen Scientific Affairs, LLC $111.75 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134262 ABBVIE INC. $23.20 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134264 ABBVIE INC. $19.62 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134266 ABBVIE INC. $15.77 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134268 ABBVIE INC. $111.93 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134270 ABBVIE INC. $21.49 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134272 ABBVIE INC. $29.28 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104134274 ABBVIE INC. $12.98 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135355672 Lilly USA, LLC $25.54 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135382185 Lilly USA, LLC $19.93 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135382187 Lilly USA, LLC $18.90 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137613043 Takeda Pharmaceuticals U.S.A., Inc. $13.15 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137613046 Takeda Pharmaceuticals U.S.A., Inc. $29.50 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137613050 Takeda Pharmaceuticals U.S.A., Inc. $13.68 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.